Searched for
UPJOHN COMPANY
Alembic Pharma gets USFDA nod for generic high blood pressure treatment drugAlembic Pharmaceuticals announced that it has secured final approval from the USFDA for its generic amlodipine and atorvastatin tablets, us...- Glenmark launches generic ophthalmic solution in US marketGlenmark Pharmaceuticals' subsidiary has introduced Latanoprost ophthalmic solution, a generic medication for glaucoma, in the US market. T...
- Pfizer offers voluntary retirement scheme for field staffOver the past few years, the company has been on a journey to reshape itself into a more growth-oriented and innovative biopharma company, ...
- Pfizer Q2 results: Net profit up 9% to Rs 143 croreRevenue from operations stood at Rs 636.26 crore for the quarter under consideration, as against Rs 595.41 crore a year ago, it added.
- Buy Pfizer, target price Rs 6500: Centrum BrokingPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 25522.43 Crore) operating in Pharmaceuticals ...
- Strides Pharma receives USFDA approval for Prednisone tabletsStrides Pharma Global Pte Limited, Singapore, has received approval for Prednisone tablets USP in the strengths of 10 mg and 20 mg from the...
- Glenmark gets USFDA nod for acne treatment drugGlenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (USFDA) for Clindamycin Phosphate Ge...
- Strides Pharma Science gets USFDA nod for Prednisone tabletsStrides Pharma Science Ltd on Monday said it has received approval from the US health regulator for its generic version of Prednisone table...
- Add Pfizer, target price Rs 3,400: Centrum BrokingManagement is hopeful of achieving in-line or slightly better growth rate than the market.
- Reduce corporate tax to 25% to kick-start investment: Kiran Mazumdar ShawQuick fixes needed so that short term demand can start kicking in, says Biocon CMD.
- Aurobindo Pharma gets USFDA nod for two generic drugsDrug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market its Tranexamic acid injection and Paricalcitol ...
- Glenmark gets USFDA final nod for anti-bacterial drug ZyvoxThe product is the therapeutic equivalent of Zyvox tablets, 600 mg of Pharmacia and Upjohn Company, a subsidiary of Pfizer, it added.
- USFDA approves Aurobindo's drugs for diarrhoea, allergyAurobindo now has a total of 224 ANDA approvals (196 final approvals, including 10 from Aurolife Pharma LLC and 28 tentative approvals) fro...
- Lupin gets USFDA nod for generic version of Mycobutin CapsulesThe approval from the US Food and Drug Administration is for Rifabutin Capsules USP, in strength of 150 mg, said Lupin in a statement.
- Pfizer gets relief in patent revocation case for anti-cancer drug 'Sutent'In a relief to pharma major Pfizer, the Intellectual Property Appellate Board here has set aside the revocation of the patent of the compan...
- Aurobindo Pharma gets USFDA nod for two drugsAurobindo Pharma today said it has received final approvals from US health regulator to sell generic versions of two separate drugs.
- HC order against Cipla's cancer drug Sunitinib stayedCipla was selling a generic version of the drug at one-fourth the price charged by Sugen Inc and Pharmacia & Upjohn Company.
- HC order against marketing of Cipla's anti-cancer drug stayedThe Supreme Court today stayed for a month a Delhi High Court order restraining pharma major Cipla from marketing its anti-cancer drug "Sun...
- Pfizer faces US probe, to pay $2.3 bnPfizer will pay $2.3 bn to settle a US investigation into illegal marketing of medicines, the largest agreement in such a case, and a subsi...
- Aurobindo gets USFDA nod for CefpodoximeAurobindo Pharma on Tuesday said it has received approval from the US Food and Drug Administration (USFDA) for its antibiotic drug Cefpodox...
Load More
